CN103262940A - Tenebrio molitor compound protein product and preparation method thereof - Google Patents
Tenebrio molitor compound protein product and preparation method thereof Download PDFInfo
- Publication number
- CN103262940A CN103262940A CN2013102373721A CN201310237372A CN103262940A CN 103262940 A CN103262940 A CN 103262940A CN 2013102373721 A CN2013102373721 A CN 2013102373721A CN 201310237372 A CN201310237372 A CN 201310237372A CN 103262940 A CN103262940 A CN 103262940A
- Authority
- CN
- China
- Prior art keywords
- yellow meal
- meal worm
- mixture
- compound protein
- aspongopus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 69
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 69
- 241000254109 Tenebrio molitor Species 0.000 title claims abstract description 64
- 150000001875 compounds Chemical class 0.000 title claims abstract description 43
- 238000002360 preparation method Methods 0.000 title claims abstract description 23
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 241000660877 Coridius Species 0.000 claims abstract description 23
- 235000006667 Aleurites moluccana Nutrition 0.000 claims abstract description 22
- 240000004957 Castanea mollissima Species 0.000 claims abstract description 22
- 235000018244 Castanea mollissima Nutrition 0.000 claims abstract description 22
- 238000001035 drying Methods 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 23
- 239000011812 mixed powder Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 5
- 241000700605 Viruses Species 0.000 abstract description 4
- 238000005469 granulation Methods 0.000 abstract description 4
- 230000003179 granulation Effects 0.000 abstract description 4
- 235000003642 hunger Nutrition 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 208000002193 Pain Diseases 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract 3
- 229940038481 bee pollen Drugs 0.000 abstract 2
- 238000000227 grinding Methods 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 244000052616 bacterial pathogen Species 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000001338 necrotic effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 55
- 210000004027 cell Anatomy 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 108010060231 Insect Proteins Proteins 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000001093 anti-cancer Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 230000017074 necrotic cell death Effects 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 239000011573 trace mineral Substances 0.000 description 5
- 235000013619 trace mineral Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 4
- 108010082126 Alanine transaminase Proteins 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 102000007330 LDL Lipoproteins Human genes 0.000 description 4
- 108010007622 LDL Lipoproteins Proteins 0.000 description 4
- 235000021120 animal protein Nutrition 0.000 description 4
- 210000000481 breast Anatomy 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000011835 investigation Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 229940109850 royal jelly Drugs 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108020004206 Gamma-glutamyltransferase Proteins 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004367 Lipase Substances 0.000 description 3
- 102000004882 Lipase Human genes 0.000 description 3
- 108090001060 Lipase Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 235000019421 lipase Nutrition 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000008935 nutritious Nutrition 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 2
- 208000037396 Intraductal Noninfiltrating Carcinoma Diseases 0.000 description 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 108010064851 Plant Proteins Proteins 0.000 description 2
- 241000382353 Pupa Species 0.000 description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000011149 active material Substances 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 208000028715 ductal breast carcinoma in situ Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000001418 larval effect Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 235000021118 plant-derived protein Nutrition 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 101100055841 Danio rerio apoa1 gene Proteins 0.000 description 1
- 206010011953 Decreased activity Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000006402 Ductal Carcinoma Diseases 0.000 description 1
- 206010013980 Dyssomnias Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 102000014160 PTEN Phosphohydrolase Human genes 0.000 description 1
- 108010011536 PTEN Phosphohydrolase Proteins 0.000 description 1
- 108090000279 Peptidyltransferases Proteins 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241001074085 Scophthalmus aquosus Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 238000011226 adjuvant chemotherapy Methods 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000087 hemolymph Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 210000003716 mesoderm Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 238000010827 pathological analysis Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 201000011531 vascular cancer Diseases 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of biology, and in particular relates to a tenebrio molitor compound protein product and a preparation method thereof. The tenebrio molitor compound protein product comprises the following raw materials: 25-45 parts of tenebrio molitors, 20-40 parts of bee larvas, 10-30 parts of aspongopus, 5-10 parts of bee pollen and 10-20 parts of Chinese chestnuts. The preparation method comprises the following steps of: drying the tenebrio molitors, the bee larvas and the aspongopus by a fire at the room temperature; mixing the dried tenebrio molitors, bee larvas and aspongopus and grinding the mixture to obtain a first mixture for standby application; shelling the Chinese chestnuts and drying the shelled Chinese chestnuts by a fire; after that, mixing the shelled and dried the Chinese chestnuts with the bee pollen and grinding the mixture to obtain a second mixture; and evenly mixing the first mixture and the second mixture. The tenebrio molitor compound protein product and the preparation method thereof can comprehensively improve the immunity of a human body, especially have the functions of diminishing inflammation and relieving pain, promoting blood circulation to remove blood stasis, softening hardness and dissolving lump as well as removing the necrotic tissue and promoting granulation, are capable of resisting pathogenic bacteria, viruses and cancers, solve the problem of cell hunger and improve sub-allogene.
Description
Technical field
The present invention relates to biological field, in particular to a kind of yellow meal worm compound protein goods and preparation method.
Background technology
Protein (protein) is the material base of life, does not have life without protein.Therefore, it be with life and be closely connected together material of various forms of vital movements.Each cell in the body and all important component parts have protein to participate in.Protein accounts for the 16%-20% of human body weight, namely in a 60kg its body of adult heavily protein 9.6-12kg is arranged approximately.The kind of human body internal protein is a lot, and character, function are different, but are all combined by different proportion by 20 several amino acids, and constantly carry out metabolism and renewal in vivo.What people's diet was eaten food reality in the body into is no more than 10% of food total amount to the useful nutrient composition content of human body, nutritional labeling for the balancing human body absorption, replenish the nutritional labeling of human body deficiency, selling on the market now has multiple protein powder product as nutritious supplementary pharmaceutical.
The problem that exists: the most plant protein powder of these protein powders, plant protein powder are difficult for being absorbed by the body, digesting.
Summary of the invention
The object of the present invention is to provide a kind of yellow meal worm compound protein goods, to address the above problem.
Another object of the present invention is to provide a kind of preparation method of yellow meal worm compound protein goods.
A kind of yellow meal worm compound protein goods that provide in an embodiment of the present invention comprise following primary raw material component:
Yellow meal worm 25-45 part, bee larva 20-40 part, aspongopus 10-30 part, melissa powder 5-10 part and Chinese chestnut 10-20 part.
A kind of preparation method of yellow meal worm compound protein goods is characterized in that, specifically may further comprise the steps:
Described yellow meal worm, bee larva and aspongopus are dried at normal temperatures;
Mixed powder is broken into first mixture, standby;
Described Chinese chestnut is shelled, dries;
Described Chinese chestnut after shelling, drying and described melissa powder are mixed, be ground into second mixture;
Described first mixture and described second mixture are mixed.
Among a kind of yellow meal worm compound protein goods provided by the invention and the preparation method, wherein,
The dry product of yellow meal worm is fatty 30%, contains protein up to more than 50%, contains macroelement and various trace elements such as phosphorus, potassium, iron, sodium, aluminium in addition.Contain 57% because the Yellow meal worm larva of drying contains protein about 40%, pupa, adult contains 60%(according to " Chinese medicine science and technology newspaper ").Be described as " protein feeds treasure-house ".So the present invention utilizes rich in protein that the bloom polypide contains and a large amount of trace element as one of main component of compound protein product.
Bee larva in queen bee whole larval phase, all feeds with royal jelly, and forever residue is arranged, the back royal cell back warp remaining dried royal jelly of not eating up often of pupating.
Aspongopus contains aspongopus oil, after drying, frying, namely is the medicinal cuisines that a kind of fragrant U.S. is good to eat, eliminate disease and prolong life.It is sweet, salty, warm in nature to distinguish the flavor of.Establishing-Yang in the energy temperature, regulating qi-flowing for relieving pain.Contain protein, fat etc.; Contain stearic acid, palmitic acid, oleic acid in the fat.
The melissa powder is the concentrate that the material of nutritious value and drug effect value is formed, and it contains protein, carbohydrate, mineral matter, vitamin and other active material.The melissa powder is fabulous natural nutrient food, also is a kind of desirable invigorant simultaneously.The natural pollen comprehensive nutrition can overcome the various disorders that occur in the human body metabolism, thereby strengthens immunity, and this is the secret that the melissa powder can be treated multiple disease.
Ripe Chinese chestnut can and the stomach invigorating the spleen, alleviate insufficiency of the spleen, increase appetite, coordinating intestines and stomach, the strong muscle of kidney tonifying, promoting blood circulation and hemostasis.
Clinical testing proves, a kind of yellow meal worm compound protein goods provided by the invention and preparation method, can improve the resistance of human body comprehensively, especially can play anti-inflammatory analgetic, promoting blood circulation and removing blood stasis, softening and resolving hard mass, the function of removing necrosis and promoting granulation, simultaneously can also disease-resistant bacterium, antiviral, anticancer and solve cell hunger, improve inferior allogene.
Description of drawings
Fig. 1 is a kind of yellow meal worm compound protein goods and the preparation method's flow chart of embodiment 1 provided by the invention;
Fig. 2 is a kind of yellow meal worm compound protein goods and the preparation method's flow chart of embodiment 2 provided by the invention.
The specific embodiment
Also by reference to the accompanying drawings the present invention is described in further detail below by specific embodiment.
Embodiment 1:
A kind of yellow meal worm compound protein goods comprise following primary raw material component:
Yellow meal worm 25-45 part, bee larva 20-40 part, aspongopus 10-30 part, melissa powder 5-10 part and Chinese chestnut 10-20 part.
Wherein, the dry product of yellow meal worm is fatty 30%, contains protein up to more than 50%, contains macroelement and various trace elements such as phosphorus, potassium, iron, sodium, aluminium in addition.Contain 57% because the Yellow meal worm larva of drying contains protein about 40%, pupa, adult contains 60%(according to " Chinese medicine science and technology newspaper ").Be described as " protein feeds treasure-house ".So the present invention utilizes rich in protein that the bloom polypide contains and a large amount of trace element as one of main component of compound protein product.
Bee larva in queen bee whole larval phase, all feeds with royal jelly, and forever residue is arranged, the back royal cell back warp remaining dried royal jelly of not eating up often of pupating.
Aspongopus contains aspongopus oil, after drying, frying, namely is the medicinal cuisines that a kind of fragrant U.S. is good to eat, eliminate disease and prolong life.It is sweet, salty, warm in nature to distinguish the flavor of.Establishing-Yang in the energy temperature, regulating qi-flowing for relieving pain.Contain protein, fat etc.; Contain stearic acid, palmitic acid, oleic acid in the fat.
The melissa powder is the concentrate that the material of nutritious value and drug effect value is formed, and it contains protein, carbohydrate, mineral matter, vitamin and other active material.The melissa powder is fabulous natural nutrient food, also is a kind of desirable invigorant simultaneously.The natural pollen comprehensive nutrition can overcome the various disorders that occur in the human body metabolism, thereby strengthens immunity, and this is the secret that the melissa powder can be treated multiple disease.
Ripe Chinese chestnut can and the stomach invigorating the spleen, alleviate insufficiency of the spleen, increase appetite, coordinating intestines and stomach, the strong muscle of kidney tonifying, promoting blood circulation and hemostasis.
As shown in Figure 1, a kind of preparation method of yellow meal worm compound protein goods is characterized in that, specifically may further comprise the steps:
101. described yellow meal worm, bee larva and aspongopus are dried at normal temperatures;
102. mixed powder is broken into first mixture, standby;
103. described Chinese chestnut is shelled, dries;
Described Chinese chestnut 104. will shell, after drying and described melissa powder mix, and are ground into second mixture;
105. described first mixture and described second mixture are mixed.
Clinical testing proves, a kind of yellow meal worm compound protein goods provided by the invention and preparation method, can improve the resistance of human body comprehensively, especially can play anti-inflammatory analgetic, promoting blood circulation and removing blood stasis, softening and resolving hard mass, the function of removing necrosis and promoting granulation, simultaneously can also disease-resistant bacterium, antiviral, anticancer and solve cell hunger, improve inferior allogene.
Insect active albumen, not only be rich in the indispensable protein of human body, free amino acid, vitamin, mineral matter element, unrighted acid, also contain chitin a large amount of, unique, valuable, that other any products do not have, that human body is highly profitable, antibacterial peptide, alexin, multiple valuable material such as ectogenous agglutinine.Wherein:
1, protein: life be unable to do without albumen, can make enzyme; The help food conversion is energy; Can help body to generate new histocyte; Increase body activity power; For immune system is made antibody, is resisted the infection of virus and bacterium.
2, chitin: the discovery of chitin ecomone is the important breakthrough of human life's science and technology, and it is described as " human life the 6th key element " by scientist.The chitin ecomone is hypoglycemic, the remarkable efficacy of blood fat, blood pressure has obtained the extensive approval of medical circle.
3, antibacterial peptide: suppress nucleic acid metabolism and the growth thereof of some cell that swells and ache, then harmless to the normal cell of human body; Can in 24 hours, kill multiple pathogen, strengthen the human immunological competence; Can suppress copying of hepatitis virus DNA, liver, kidney are played a protective role.
4, ectogenous agglutinine: can promote cell mutually bonding and have and suppress it and rub the function of growing.It can effectively defend and treat cancer, also helps to prevent the generation of enteritis and infectious diseases.
5, alexin: belong to micromolecule polypeptide, can produce stronger killing action to pathogenic microorganisms such as bacterium, virus, fungies, can prevent multiple communicable disease caused by the bacteria effectively.
6, amino acid: be the base unit that constitutes protein, insect active albumen contains the essential amino acid more than 8 kinds, than all animal protein height, intelligence development and the growth that improves children is had good effect.
7, vitamin: be the healthy necessary material that earns a bare living, wherein the content of the content of fat-soluble A, D and water-soluble (vitamin) B family is very abundant, and particularly the B2 that lacks in the cereal and B12 content are higher, are respectively 28.8 and 188.
8, mineral matter element: not only contain outside the macroelements such as potassium, sodium, calcium, magnesium, iron, also contain trace elements such as the required zinc of the multiple activity that earns a bare living, manganese, brill, chromium, selenium, boron, iodine, copper.
Embodiment 2:
A kind of yellow meal worm compound protein goods comprise following primary raw material component:
15 parts of 35 parts of yellow meal worms, 30 parts of bee larvas, 20 parts of aspongopus, 5 parts in melissa powder and Chinese chestnuts.
As shown in Figure 2, a kind of preparation method of yellow meal worm compound protein goods specifically may further comprise the steps:
201. described yellow meal worm, described bee larva and described aspongopus are cleaned up;
202. with described yellow meal worm, bee larva and aspongopus dry at normal temperatures to moisture less than 12%;
203. it is 800 purposes, first mixture, standby that mixed powder is broken into fineness;
204. with described Chinese chestnut shell, dry under the normal temperature to moisture less than 12%;
Described Chinese chestnut 205. will shell, after drying and described melissa powder mix, and being ground into fineness is 500 purposes, second mixtures;
206. described first mixture and described second mixture are mixed;
207. packing.
Clinical testing proves, a kind of yellow meal worm compound protein goods provided by the invention and preparation method, can improve the resistance of human body comprehensively, especially can play anti-inflammatory analgetic, promoting blood circulation and removing blood stasis, softening and resolving hard mass, the function of removing necrosis and promoting granulation, simultaneously can also disease-resistant bacterium, antiviral, anticancer and solve cell hunger, improve inferior allogene.
Clinical testing:
Experimental example 1:
Mr. Zhang, 47 years old, take before the yellow meal worm compound protein goods provided by the invention:
Learn 94 units that exceed standard of the glutamic-pyruvic transaminase in its body through the biochemical investigation of Pinggu District, Beijing hospital laboratory report; Glutamic-oxalacetic transaminease 46 units that exceed standard; Glutamyl transpeptidase 185 units that exceed standard; Glucose 0.13 unit that exceeds standard; Cholesterol 2.01 units that exceed standard; Triglycerides 0.21 unit that exceeds standard; HDL 0.27 unit that exceeds standard; Low-density lipoprotein 1.18 units that exceed standard.
Take after the yellow meal worm compound protein goods provided by the invention 12 days:
It is normal that the index of glutamic-pyruvic transaminase, glutamic-oxalacetic transaminease, glucose, triglycerides, HDL all recovers;
Glutamyl transpeptidase is reduced to 103 units, and cholesterol is reduced to 5.4 units, and low-density lipoprotein is reduced to 4.27 units.
Experimental example 2:
Mr. Geng, 42 years old, take before the yellow meal worm compound protein goods provided by the invention:
Learn through the biochemical investigation of Pinggu District, Beijing hospital laboratory report, in its body
Glutamyl transpeptidase is 17.8, and 30 units are below the normal; Fasting blood-glucose is 23.92, and 17 units exceed standard; Homocysteine is 16.9 units, and 1.9 units exceed standard; Lipase is 88, and 28 units exceed standard.
Take after the yellow meal worm compound protein goods provided by the invention 12 days:
Fasting blood-glucose is reduced to 16.6 units; It is normal that homocysteine and lipase all recover.
Experimental example 3:
Mr. Liu, 61 years old, take before the yellow meal worm compound protein goods provided by the invention:
Biochemical investigation report through Pinggu District, Beijing hospital laboratory is learnt, glutamic-pyruvic transaminase in its body 4 units that exceed standard, fasting blood-glucose 1 unit that exceeds standard, creatinine 10 units that exceed standard, uric acid 68 units that exceed standard, 10 units that exceed standard of low-density lipoprotein 0.62 unit that exceeds standard, lipase, magnesium is lower than 0.71 unit of standard value.
Take after the yellow meal worm compound protein goods provided by the invention 12 days: recover normal fully.
Experimental example 4:
Mr. Zhang, 41 years old, take before the yellow meal worm compound protein goods provided by the invention:
Survey report through the People's Hospital, Qingfeng County biochemical investigation section learns,
Glutamic-oxalacetic transaminease in its body 7 units that exceed standard, lactic dehydrogenase 9 units that exceed standard, 3 units that exceed standard of 70 units that exceed standard of glutamic-pyruvic transaminase 140 units that exceed standard, paddy acyl transpeptidase, alkaline phosphatase, total bilirubin 5 units that exceed standard, 2 units that exceed standard of 0.6 unit that exceeds standard of bilirubin direct 4 units that exceed standard, T-CHOL, glycerine triol, low-density lipoprotein 1 unit that exceeds standard, 0.8 unit of the aPoA value of being below the normal.
Take after the yellow meal worm compound protein goods provided by the invention 50 days: all indexs recover normal fully.
Experimental example 5:
Mrs Xu, 30 years old, take before the yellow meal worm compound protein goods provided by the invention:
On May 26th, 2011, learn through the pathologic finding report of northern Peking University First Hospital: go up swollen thing CNB, infiltration ductal carcinomas of breast, non-special type, 11 grades, 6 minutes in the right breast.Rank intraductal carcinoma among the companion, chamber internals acne shape necrosis.LEC:ER90% is sun by force, HER2(4B5)-+-, CK5/6-, EGFR-, TOP11A20%, PTEN endochylema and nuclear cun sun, P53-, P120++-, P63-, KI67.70%.
Take after the yellow meal worm compound protein goods provided by the invention 5 months:
On October 24th, 2011, learn through the pathologic finding report of Peking University First Hospital again: pathological diagnosis result: freezing paraffin: (right side) protects breast conserving surgery excision sample (behind the new adjuvant chemotherapy): see a greyish white pars fibrosa in the censorship breast tissue, the about 4.5x1.2x1cm of size, see IDC in it, non-special type, 11 grades, 6 minutes, (1/2 square millimeter of nuclear fission), the about 3.5x0.6x0.5cm of distribution, rank intraductal carcinoma and smooth epithelium atypical hyperplasia among the companion, the extensive sex change of tumour cell, necrosis and calcification, the infiltrating cancer cell density is about 5%, reads former CNB pathological section 2011-9033 again, cancer cell density about 25%.Histological assessment can meet Miller and Payne system Grade3 after this case chemotherapy.The extensive collagenzation of mesenchyma stroma of tumors, visible lymphocyte reaction is not seen vascular cancer embolus and nerve infiltration.Tumour is apart from substrate incisxal edge 2.5mm, surperficial incisxal edge 8.8mm, and (9 °) incisxal edge 2.5mm, (12 °) incisxal edge 4mm, (3 °) (6 °) incisxal edge is all greater than 1cm.
EHC:ER90% is sun by force, and PR90% is sun by force, HER2(4B5) ++, CK/6-, EGFR-, TOP PTE+.P53:50%, P120-++, P63-, KI67:20%.
Formulation: be generally capsule, every dose of 350mg.Also can make the powder electuary.
Instructions of taking: take first three day, morning and evening every day twice, each one; Every day twice afterwards, each five.Do not have taboo, old children all can take.
Simultaneously, yellow meal worm compound protein goods provided by the invention can also be made the alcoholic drink mixed with fruit juice form.
Find that according to relevant fossil data statistics caste has nearly more than 100 ten thousand kinds, account for 4/5 of the whole animal kingdom, it is the animal population of living nature maximum, China bioengineering expert studies show that through the more than ten years, the content of free amino acid is about mammiferous 50-100 doubly in the insect hemolymph, contains 18 kinds of needed by human with upper amino acid. take in the needs that a certain amount of insect protein just can satisfy human body every day.Assist the center clinical observation to confirm through the Shanghai City dietotherapy, insect protein is remarkable to the regulating action of body immunity underactivity. comprising susceptible fatigue, weak and sickly, influenza, dyssomnias, neurasthenia, joint pain, headache, constipation. and abdominal distension, hepatitis, pneumonia, dermatitis and chronic gastritis, stomach, duodenal ulcer, multiple canker sore and diabetes, coronary heart disease, the symptom that hypoimmunity reasons such as hypertension cause, the result that the insect protein dietotherapy improves is respectively 90%, 96%, 99%, 83% and 92%.It is reported, as far back as the early 1980s Nihon University name get pretty two professors and in the research report to insect protein, point out: insect protein has powerful sterilization, antibiotic and anticancer effect.The early 1990s, the antibacterial protein that Britain Royal Society of Medicine extract the insect young is classified anticancer choice drug of 21st century as.The pollution-free industry Committee of Experts of the United Nations assert that the New Times that the insect biology is succeeded in developing with health is about to spread all over the world.
The present invention utilizes yellow meal worm, aspongopus and bee larva not only nontoxic, and body contains rich in protein, has added melissa powder and rice-chestnut powder simultaneously, can improve the resistance of human body comprehensively.
Protein, especially animal protein Excessive Intake are harmful equally to human body.The absorption of at first too much animal protein just must be taken in more animal tallow and cholesterol.Too much animal protein is taken in, and also causes the sulfur-containing amino acid Excessive Intake, can accelerate calcareous losing in the bone like this, easily produces osteoporosis.
The above is the preferred embodiments of the present invention only, is not limited to the present invention, and for a person skilled in the art, the present invention can have various changes and variation.Within the spirit and principles in the present invention all, any modification of doing, be equal to replacement, improvement etc., all should be included within protection scope of the present invention.
Claims (10)
1. yellow meal worm compound protein goods is characterized in that, comprise following primary raw material component:
Yellow meal worm 25-45 part, bee larva 20-40 part, aspongopus 10-30 part, melissa powder 5-10 part and Chinese chestnut 10-20 part.
2. a kind of yellow meal worm compound protein goods according to claim 1 is characterized in that, comprise following primary raw material component:
Yellow meal worm 30-35 part, bee larva 25-35 part, aspongopus 15-25 part, melissa powder 6-8 part and Chinese chestnut 13-18 part.
3. a kind of yellow meal worm compound protein goods according to claim 1 is characterized in that, comprise following primary raw material component:
15 parts of 35 parts of yellow meal worms, 30 parts of bee larvas, 20 parts of aspongopus, 5 parts in melissa powder and Chinese chestnuts.
4. according to the preparation method of each described a kind of yellow meal worm compound protein goods of claim 1-3, it is characterized in that, specifically may further comprise the steps:
Described yellow meal worm, bee larva and aspongopus are dried at normal temperatures;
Mixed powder is broken into first mixture, standby;
Described Chinese chestnut is shelled, dries;
Described Chinese chestnut after shelling, drying and described melissa powder are mixed, be ground into second mixture;
Described first mixture and described second mixture are mixed.
5. the preparation method of a kind of yellow meal worm compound protein goods according to claim 4 is characterized in that,
Before the described step that described yellow meal worm, bee larva and aspongopus are dried at normal temperatures, further comprise:
Described yellow meal worm, described bee larva and described aspongopus are cleaned up.
6. the preparation method of a kind of yellow meal worm compound protein goods according to claim 4 is characterized in that,
In the described step that described yellow meal worm, bee larva and aspongopus are dried at normal temperatures, specifically comprise:
Described yellow meal worm, described bee larva and described aspongopus dried at normal temperatures to moisture be less than 12%.
7. the preparation method of a kind of yellow meal worm compound protein goods according to claim 4 is characterized in that,
In the described step that described Chinese chestnut is shelled, dries, specifically comprise:
With the described Chinese chestnut after shelling dry at normal temperatures to moisture less than 12%.
8. the preparation method of a kind of yellow meal worm compound protein goods according to claim 4 is characterized in that,
The fineness of described first mixture and described second mixture is the 300-800 order.
9. the preparation method of a kind of yellow meal worm compound protein goods according to claim 4 is characterized in that,
After the described step that described first mixture and described second mixture are mixed, further comprise:
Packing.
10. the preparation method of a kind of yellow meal worm compound protein goods according to claim 9 is characterized in that,
In the step of described packing, specifically comprise:
Make tablet, pill or capsule, every dose protein content is 350-400mg.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310237372.1A CN103262940B (en) | 2013-06-14 | 2013-06-14 | Tenebrio molitor compound protein product and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310237372.1A CN103262940B (en) | 2013-06-14 | 2013-06-14 | Tenebrio molitor compound protein product and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103262940A true CN103262940A (en) | 2013-08-28 |
| CN103262940B CN103262940B (en) | 2014-10-08 |
Family
ID=49006642
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310237372.1A Expired - Fee Related CN103262940B (en) | 2013-06-14 | 2013-06-14 | Tenebrio molitor compound protein product and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103262940B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4296C1 (en) * | 2012-12-28 | 2015-03-31 | Вячеслав ЧУХРИЙ | Preparation from Tenebrio molitor larvae with antioxidant activity, process for its preparation and pharmaceutical product on its base |
| CN104799106A (en) * | 2015-05-07 | 2015-07-29 | 郑州立蓓生物工程有限公司 | Insect protein containing protein powder for pets |
| CN115515436A (en) * | 2020-04-23 | 2022-12-23 | Cj第一制糖株式会社 | Composition for improving intestinal motility containing extract of larvae of Metarhizium dichotomum |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1802983A (en) * | 2006-01-20 | 2006-07-19 | 山东农业大学 | Three kinds of insect powder and its making method |
| CN101116471A (en) * | 2006-08-01 | 2008-02-06 | 西安市轻工业研究所 | Edible insect albumen powder and the production process and application thereof |
| CN101617826A (en) * | 2009-08-03 | 2010-01-06 | 李光博 | Health preserving meal |
| WO2011126873A2 (en) * | 2010-03-30 | 2011-10-13 | Alvine Pharmaceuticals, Inc. | Proteases for degrading gluten |
-
2013
- 2013-06-14 CN CN201310237372.1A patent/CN103262940B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1802983A (en) * | 2006-01-20 | 2006-07-19 | 山东农业大学 | Three kinds of insect powder and its making method |
| CN101116471A (en) * | 2006-08-01 | 2008-02-06 | 西安市轻工业研究所 | Edible insect albumen powder and the production process and application thereof |
| CN101617826A (en) * | 2009-08-03 | 2010-01-06 | 李光博 | Health preserving meal |
| WO2011126873A2 (en) * | 2010-03-30 | 2011-10-13 | Alvine Pharmaceuticals, Inc. | Proteases for degrading gluten |
Non-Patent Citations (1)
| Title |
|---|
| 习牧: "加大昆虫资源开发力度 开创食品新产业", 《动物科学与动物医学》, vol. 16, no. 2, 31 May 1999 (1999-05-31), pages 43 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD4296C1 (en) * | 2012-12-28 | 2015-03-31 | Вячеслав ЧУХРИЙ | Preparation from Tenebrio molitor larvae with antioxidant activity, process for its preparation and pharmaceutical product on its base |
| CN104799106A (en) * | 2015-05-07 | 2015-07-29 | 郑州立蓓生物工程有限公司 | Insect protein containing protein powder for pets |
| CN115515436A (en) * | 2020-04-23 | 2022-12-23 | Cj第一制糖株式会社 | Composition for improving intestinal motility containing extract of larvae of Metarhizium dichotomum |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103262940B (en) | 2014-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103027231B (en) | Compound probiotics fermented Chinese herbal medicine active health care liquid and preparation method thereof | |
| CN103141712B (en) | Compound feed for laying hens in egg producing period and preparation method of feed | |
| CN102150764B (en) | Feed for meat ducks aged 0-21 days and preparation method thereof | |
| CN102940155B (en) | Duckling feed for cherry valley duck and preparation method thereof | |
| CN103355555A (en) | Feed for laying hen in egg-laying peak stage and preparation method thereof | |
| KR101646156B1 (en) | Fermented foods improve bowel function and a method of manufactuing stercoral removal efficacy | |
| KR20120107557A (en) | Rice bran fermentation extracts with chlorophyll and the manufacturing method thereof | |
| WO2017003206A1 (en) | Method for producing raw pills of fermented minerals having functions of improving constipation and recovery from fatigue, and raw pills of fermented minerals produced thereby | |
| CN105624288A (en) | Toxin accumulation type obese gene individual treatment composition and preparing method and system thereof | |
| CN107927512A (en) | A kind of oligopeptide weight losing meal-replacing solid beverage | |
| CN104783003A (en) | Chinese herbal medicine complete feed for piglets and preparation method of Chinese herbal medicine complete feed | |
| CN106819854A (en) | A kind of barley young leaf composite powder and preparation method thereof | |
| CN100444746C (en) | A refined health food of high and cold mountain area crop and processing technology thereof | |
| CN103262940B (en) | Tenebrio molitor compound protein product and preparation method thereof | |
| CN106173450A (en) | Improve compound feed additive and the feedstuff of pigeon immunity | |
| CN103238757B (en) | Compound feed containing fermented cottonseed meal for chicken for eggs and preparation method thereof | |
| Lokhande et al. | Immune boosting super food supplement from natural resources | |
| CN103933146A (en) | Pollen product capable of adjusting human body immunity | |
| KR20190046144A (en) | Method of manufacturing food additive | |
| CN106138215A (en) | A kind of medicine for treating eczema | |
| WO2019083074A1 (en) | Food additive and natural functional food | |
| CN1190235C (en) | Process for preparing health-care compound sheep placenta extract food series | |
| CN106418266A (en) | Qi circulation promoting and pain relieving clematis fasciculiflora franch duck egg and preparation method thereof | |
| CN105194237A (en) | Composition for treating lymphoma and preparation method of composition | |
| CN104840764A (en) | Traditional Chinese medicine preparation for treating improper-eating acute infantile diarrhea and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141008 |